Molecular predictors of response to selinexor in recurrent glioblastoma (GBM).

被引：0
|
作者：
Walker, Christopher James
Shen, Yao
Mau-Sorensen, Morten
Wen, Patrick Y.
Van den Bent, Martin J.
Plotkin, Scott Randall
Walenkamp, Anna Maria Elisabeth
Green, Adam
Califano, Andrea
Chang, Hua
Henegar, Leah
Shacham, Sharon
Alvarez, Mariano J.
Landesman, Yosef
Lassman, Andrew B.
机构：
[1] Karyopharm Therapeut Inc, Newton, MA USA
[2] DarwinHealth Inc, New York, NY USA
[3] Rigshosp, Copenhagen, Denmark
[4] Harvard Med Sch, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA
[5] Erasmus MC Canc Inst, Rotterdam, Netherlands
[6] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands
[8] Univ Colorado, Sch Med, Childrens Hosp Colorado, Ctr Canc & Blood Disorders,Dept Pediat, Aurora, CO USA
[9] Columbia Univ, Irving Med Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2565
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MOLECULAR PREDICTORS OF RESPONSE TO SELINEXOR IN RECURRENT GLIOBLASTOMA (GBM)
    Walker, Christopher
    Shen, Yao
    Mau-Soerensen, Morten
    Wen, Patrick
    van den Bent, Martin
    Plotkin, Scott
    Walenkamp, Annemiek
    Green, Adam
    Califano, Andrea
    Chang, Hua
    Tamir, Sharon
    Henegar, Leah
    Shacham, Sharon
    Alvarez, Mariano
    Landesman, Yosef
    Lassman, Andrew
    [J]. NEURO-ONCOLOGY, 2020, 22 : 7 - 7
  • [2] EFFICACY AND SAFETY OF SELINEXOR IN RECURRENT GLIOBLASTOMA
    Lassman, A. B.
    Wen, P. Y.
    van den Bent, M.
    Plotkin, S. R.
    Walenkamp, A.
    Green, A.
    Huang, X.
    Rodriguez-Lopez, K. Karla
    Kauffman, M. G.
    Shacham, S.
    Mau-Soerensen, M.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 3 - 4
  • [3] Efficacy and Safety of Selinexor in Recurrent Glioblastoma
    Lassman, A. B.
    Wen, P. Y.
    van den Bent, M.
    Plotkin, S. R.
    Walenkamp, A.
    Green, A.
    Huang, X.
    Rodriguez-Lopez, K. Karla
    Kauffman, M. G.
    Shacham, S.
    Mau-Soerensen, M.
    [J]. NEUROTHERAPEUTICS, 2020, 17 (03) : 1315 - 1316
  • [4] IPILIMUMAB FOR RECURRENT GLIOBLASTOMA (GBM)
    Schaff, Lauren R.
    Lassman, Andrew B.
    Goldlust, Samuel A.
    Cloughesy, Timothy
    Singer, Samuel
    Schwartz, Gary K.
    Iwamoto, Fabio M.
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [5] Efficacy and safety of selinexor in recurrent glioblastoma.
    Lassman, Andrew B.
    Wen, Patrick Y.
    Van den Bent, Martin J.
    Plotkin, Scott Randall
    Walenkamp, Anna Maria Elisabeth
    Huang, Xiu
    Rodriguez-Lopez, Karla
    Kauffman, Michael G.
    Shacham, Sharon
    Mau-Sorensen, Morten
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] STEREOTACTIC RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA (GBM)
    Anselmo, P.
    Maranzano, E.
    Casale, M.
    Trippa, F.
    Italiani, M.
    Rossi, R.
    Di Palma, A.
    Chirico, L.
    Basagni, M. L.
    Giorgi, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S272 - S272
  • [7] Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
    Silvia Chiesa
    Antonella Mangraviti
    Maurizio Martini
    Tonia Cenci
    Ciro Mazzarella
    Simona Gaudino
    Serena Bracci
    Antonella Martino
    Giuseppe M. Della Pepa
    Martina Offi
    Marco Gessi
    Rosellina Russo
    Matia Martucci
    Francesco Beghella Bartoli
    Luigi M. Larocca
    Liverana Lauretti
    Alessandro Olivi
    Roberto Pallini
    Mario Balducci
    Quintino Giorgio D’Alessandris
    [J]. Scientific Reports, 12
  • [8] A phase 2 study on efficacy, safety and intratumoral pharmacokinetics of oral selinexor (KPT-330) in patients with recurrent glioblastoma (GBM).
    Lassen, Ulrik Niels
    Mau-Soerensen, Morten
    Kung, Andrew L.
    Wen, Patrick Y.
    Lee, Eudocia Quant
    Plotkin, Scott R.
    Muhic, Aida
    Rashal, Tami
    Williams, Tony
    McCauley, Dilara
    Ellis, Joel
    Saint-Martin, Jean-Richard
    Carlson, Robert
    Frenkel, Ran
    Shacham, Sharon
    Mirza, Mansoor Raza
    Kauffman, Michael
    Lassman, Andrew B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
    Chiesa, Silvia
    Mangraviti, Antonella
    Martini, Maurizio
    Cenci, Tonia
    Mazzarella, Ciro
    Gaudino, Simona
    Bracci, Serena
    Martino, Antonella
    Della Pepa, Giuseppe M.
    Offi, Martina
    Gessi, Marco
    Russo, Rosellina
    Martucci, Matia
    Bartoli, Francesco Beghella
    Larocca, Luigi M.
    Lauretti, Liverana
    Olivi, Alessandro
    Pallini, Roberto
    Balducci, Mario
    D'Alessandris, Quintino Giorgio
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] A phase 2 study on efficacy, safety and intratumoral pharmacokinetics of oral selinexor (KPT-330) in patients with recurrent glioblastoma (GBM).
    Mau-Sorensen, Morten
    Plotkin, Scott Randall
    Wen, Patrick Y.
    Kung, Andrew L.
    Lassen, Ulrik Niels
    Saint-Martin, Jean-Richard
    Wright, Greg
    Chudnovsky, Aleksander
    Ellis, Joel
    Friedlander, Sharon
    van Eijk, Bert
    Shacham, Sharon
    Kauffman, Michael G.
    Lassman, Andrew B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345